首页 > 最新文献

Asian Journal of Pharmacy and Technology最新文献

英文 中文
To Study In-Vitro Antimicrobial Activity of Polyherbal Handwash Formulation 研究复方洗手液的体外抗菌活性
Pub Date : 2022-08-10 DOI: 10.52711/2231-5713.2022.00039
Tushar Rukari, N. Pawar, Swapnali Gawas, Jaydeep Bhoite, Priyanka Jadhav, Saylee Madkholkar, V. Jagtap
The COVID-19 pandemic provides an important reminder that one of the most effective ways to stop the spread of germs and stay healthy is also one of the simplest — handwashing. Numerous side effects and increased antimicrobial drugs resistance encouraged us to discover cost effective, secure formulation of herbal plants. In the present study, research work is focused on evaluating the potential of different formulation incorporated with different herbal extracts against antimicrobe. This Polyherbal formulated handwash presents the efficacious study of 3 herbs consisting Andrographis peniculata, Zingiber officinalis and Citrus limon reflecting antimicrobial activity. The aim of present work is to avoid the adverse effects of synthetic formulation. An attempt has been made to formulate this polyherbal handwash by Maceration method of extraction. Followed by formulating then testing. The antimicrobial activity of prepared handwashes was checked against skin pathogens by diffusion wall method. Different combination of ingredients with plant extracts were tested to evaluate the antimicrobial activity by proper zone of inhibition. Thus, these extracts, showed maximum activity with strains of E. coli i.e., gram negative bacteria and Staphylococcus aureus i.e., gram positive bacteria and were found more potent than marketed preparation. Different evaluation parameter i.e., physical testing, pH, foaming, viscosity etc. were carried out on the formulation of different grades. This study “result” divulges that development of Polyherbal Handwash could have great potential for superficial hygiene of hands in turn thus trigger the good health. The usefulness of polyherbal handwash consisting of Andrographis peniculata, Zingiber officinalis, Citrus limoni against most common pathogens in dermatology, suggesting possible role in treating multidrug-resistant mixed infections. This action may be attributed to the synergistic effects for its use. Thus, proved to be most effective product over Healthy Human Hygiene.
2019冠状病毒病大流行提醒我们,阻止细菌传播和保持健康的最有效方法之一也是最简单的方法之一——洗手。众多的副作用和增加的抗微生物药物耐药性鼓励我们发现成本效益高,安全的草药配方。在本研究中,研究工作的重点是评估不同配方中不同草药提取物的抗菌潜力。本复方洗手液对穿心莲、生姜和柠檬三种中药进行了抗菌活性研究。本工作的目的是避免合成配方的不良影响。本文尝试用浸渍法提取复方洗手液。然后是配方,然后是测试。采用扩散壁法测定制备的洗手液对皮肤病原菌的抑菌活性。研究了不同成分与植物提取物的组合,以确定合适的抑菌区来评价其抑菌活性。因此,这些提取物对大肠杆菌(即革兰氏阴性菌)和金黄色葡萄球菌(即革兰氏阳性菌)的活性最大,并且发现比市售制剂更有效。对不同牌号的配方进行了不同的评价参数,即物理测试、pH、发泡、粘度等。这项研究的“结果”揭示了复方洗手液的开发可能会对手部的表面卫生有很大的潜力,从而引发良好的健康。由穿心莲、青姜、柠檬组成的复方洗手液对皮肤病学中大多数常见病原体的有效性,提示可能在治疗多药耐药混合感染中发挥作用。这种作用可归因于其使用的协同效应。因此,证明是最有效的产品超过健康的人类卫生。
{"title":"To Study In-Vitro Antimicrobial Activity of Polyherbal Handwash Formulation","authors":"Tushar Rukari, N. Pawar, Swapnali Gawas, Jaydeep Bhoite, Priyanka Jadhav, Saylee Madkholkar, V. Jagtap","doi":"10.52711/2231-5713.2022.00039","DOIUrl":"https://doi.org/10.52711/2231-5713.2022.00039","url":null,"abstract":"The COVID-19 pandemic provides an important reminder that one of the most effective ways to stop the spread of germs and stay healthy is also one of the simplest — handwashing. Numerous side effects and increased antimicrobial drugs resistance encouraged us to discover cost effective, secure formulation of herbal plants. In the present study, research work is focused on evaluating the potential of different formulation incorporated with different herbal extracts against antimicrobe. This Polyherbal formulated handwash presents the efficacious study of 3 herbs consisting Andrographis peniculata, Zingiber officinalis and Citrus limon reflecting antimicrobial activity. The aim of present work is to avoid the adverse effects of synthetic formulation. An attempt has been made to formulate this polyherbal handwash by Maceration method of extraction. Followed by formulating then testing. The antimicrobial activity of prepared handwashes was checked against skin pathogens by diffusion wall method. Different combination of ingredients with plant extracts were tested to evaluate the antimicrobial activity by proper zone of inhibition. Thus, these extracts, showed maximum activity with strains of E. coli i.e., gram negative bacteria and Staphylococcus aureus i.e., gram positive bacteria and were found more potent than marketed preparation. Different evaluation parameter i.e., physical testing, pH, foaming, viscosity etc. were carried out on the formulation of different grades. This study “result” divulges that development of Polyherbal Handwash could have great potential for superficial hygiene of hands in turn thus trigger the good health. The usefulness of polyherbal handwash consisting of Andrographis peniculata, Zingiber officinalis, Citrus limoni against most common pathogens in dermatology, suggesting possible role in treating multidrug-resistant mixed infections. This action may be attributed to the synergistic effects for its use. Thus, proved to be most effective product over Healthy Human Hygiene.","PeriodicalId":8527,"journal":{"name":"Asian Journal of Pharmacy and Technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81690543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
A Short Review on Floating Drug Delivery System 漂浮给药系统研究进展综述
Pub Date : 2022-08-10 DOI: 10.52711/2231-5713.2022.00044
Nikam Aaditya R., Nikum Ashwini C., Shaikh Azam Z.
In the latest years, scientific and technical progresses have been made in the study and progress of novel drug delivery systems by overcoming physiological difficulties such as short gastric residence times and unpredictable gastric emptying times. Gastric emptying of dose form is extremely variable process and ability to prolong and control the emptying time. Gastric transit time is valuable asset for dosage forms, which reside in the stomach for a long period of time than conventional dosage form. Several approaches are currently utilized in the prolongation of the gastric residence times, including floating drug delivery systems, swelling and expanding systems, polymeric bioadhesive systems, modified-shape systems, high-density systems and other delayed gastric emptying devices. The purpose of writing this review on floating drug delivery systems (FDDS) was to compile the recent literature with special focus on the principal mechanism of floatation to achieve gastric retention. This review explains briefly about types of floating system, advantages, limitation, floating mechanism, factors affecting floating system, drug candidates suitable for floating, evaluation parameters and application of the system.
近年来,克服胃停留时间短、胃排空时间不可预测等生理困难,新型给药系统的研究和进展取得了科技进步。剂型胃排空是一个多变的过程,具有延长和控制排空时间的能力。胃转运时间是剂型的宝贵资产,与传统剂型相比,它在胃中停留的时间更长。目前有几种方法用于延长胃停留时间,包括浮式给药系统、肿胀和膨胀系统、聚合物生物粘合剂系统、修饰形状系统、高密度系统和其他延迟胃排空装置。撰写这篇关于漂浮给药系统(FDDS)的综述的目的是汇编最近的文献,特别关注漂浮实现胃潴留的主要机制。本文简要介绍了漂浮体系的类型、优点、局限性、漂浮机制、影响漂浮体系的因素、适合漂浮的候选药物、评价参数以及漂浮体系的应用。
{"title":"A Short Review on Floating Drug Delivery System","authors":"Nikam Aaditya R., Nikum Ashwini C., Shaikh Azam Z.","doi":"10.52711/2231-5713.2022.00044","DOIUrl":"https://doi.org/10.52711/2231-5713.2022.00044","url":null,"abstract":"In the latest years, scientific and technical progresses have been made in the study and progress of novel drug delivery systems by overcoming physiological difficulties such as short gastric residence times and unpredictable gastric emptying times. Gastric emptying of dose form is extremely variable process and ability to prolong and control the emptying time. Gastric transit time is valuable asset for dosage forms, which reside in the stomach for a long period of time than conventional dosage form. Several approaches are currently utilized in the prolongation of the gastric residence times, including floating drug delivery systems, swelling and expanding systems, polymeric bioadhesive systems, modified-shape systems, high-density systems and other delayed gastric emptying devices. The purpose of writing this review on floating drug delivery systems (FDDS) was to compile the recent literature with special focus on the principal mechanism of floatation to achieve gastric retention. This review explains briefly about types of floating system, advantages, limitation, floating mechanism, factors affecting floating system, drug candidates suitable for floating, evaluation parameters and application of the system.","PeriodicalId":8527,"journal":{"name":"Asian Journal of Pharmacy and Technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77823478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Epidemiological Study on complications of Diabetes and its Treatment Options 糖尿病并发症的流行病学研究及治疗方案
Pub Date : 2022-03-05 DOI: 10.52711/2231-5713.2022.00007
S. Sivaprasad
Diabetes is a major health hazard with its attendant acute and long-term complications. Globally type-2 diabetes were 15.1 million in 2000. The number of people with diabetes worldwide is projected to increase to 36.6 million by 2030. Diabetes incidence is higher in developing countries than developed countries. A physician’s based study was carried out in 4 Rayalaseema districts, Kadapa, Anantapuramu, Kurnool and Chittor. About 100 physicians who include Diabetologists, Cardiologists and General Physicians were interviewed using a structured questionnaire to determine the prevalence of diabetic complications and their possible treatment options. Physicians responded that about 46% of the diabetic population was having associated complications like diabetic hypertension, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy and diabetic foot. Among those females showing a significantly higher prevalence than males. Among the diabetics, the prevalence of diabetic hypertension, diabetic neuropathy, diabetic nephropathy, diabetic foot, diabetic gastroparesis and diabetic retinopathy were 30%, 25%, 15%, 10%, 8% and 7% of the patients respectively. The prevalence of the diabetes and its associated complications were increased with age and duration of the diabetes. All the diabetic populations need to be treated with suitable prevention and control strategies. As the prevention is better than cure community programmes need to be implemented to create the awareness among the diabetic population.
糖尿病是一种主要的健康危害,伴有急性和长期并发症。2000年,全球2型糖尿病患者为1510万人。到2030年,全球糖尿病患者人数预计将增加到3660万。发展中国家的糖尿病发病率高于发达国家。在4个Rayalaseema区、Kadapa、Anantapuramu、Kurnool和Chittor进行了一项以医生为基础的研究。约100名医生,包括糖尿病专家、心脏病专家和普通内科医生接受了结构化问卷调查,以确定糖尿病并发症的患病率及其可能的治疗方案。医生回答说,大约46%的糖尿病患者有糖尿病高血压、糖尿病神经病变、糖尿病肾病、糖尿病视网膜病变和糖尿病足等相关并发症。在这些人中,女性的患病率明显高于男性。糖尿病患者中,糖尿病高血压、糖尿病神经病变、糖尿病肾病、糖尿病足、糖尿病胃轻瘫和糖尿病视网膜病变的患病率分别为30%、25%、15%、10%、8%和7%。糖尿病及其相关并发症的患病率随着年龄和病程的增加而增加。所有的糖尿病人群都需要适当的预防和控制策略。预防胜于治疗,因此需要实施社区规划,以提高糖尿病人群的认识。
{"title":"Epidemiological Study on complications of Diabetes and its Treatment Options","authors":"S. Sivaprasad","doi":"10.52711/2231-5713.2022.00007","DOIUrl":"https://doi.org/10.52711/2231-5713.2022.00007","url":null,"abstract":"Diabetes is a major health hazard with its attendant acute and long-term complications. Globally type-2 diabetes were 15.1 million in 2000. The number of people with diabetes worldwide is projected to increase to 36.6 million by 2030. Diabetes incidence is higher in developing countries than developed countries. A physician’s based study was carried out in 4 Rayalaseema districts, Kadapa, Anantapuramu, Kurnool and Chittor. About 100 physicians who include Diabetologists, Cardiologists and General Physicians were interviewed using a structured questionnaire to determine the prevalence of diabetic complications and their possible treatment options. Physicians responded that about 46% of the diabetic population was having associated complications like diabetic hypertension, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy and diabetic foot. Among those females showing a significantly higher prevalence than males. Among the diabetics, the prevalence of diabetic hypertension, diabetic neuropathy, diabetic nephropathy, diabetic foot, diabetic gastroparesis and diabetic retinopathy were 30%, 25%, 15%, 10%, 8% and 7% of the patients respectively. The prevalence of the diabetes and its associated complications were increased with age and duration of the diabetes. All the diabetic populations need to be treated with suitable prevention and control strategies. As the prevention is better than cure community programmes need to be implemented to create the awareness among the diabetic population.","PeriodicalId":8527,"journal":{"name":"Asian Journal of Pharmacy and Technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73560818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Mucormycosis: A Lethal Disease 毛霉病:一种致命的疾病
Pub Date : 2022-03-05 DOI: 10.52711/2231-5713.2022.00008
P. Karwa, Jyoti K. Soundarmal, Pallavi S. Shinde, Swapna R. Jalde
Mucormycosis is an emerging infection associated with high mortality. These fungi are very common molds to which exposure is probably quite frequent, still, clinical disease is rare and affects severely immunocompromised patients or patients with diabetes mellitus. Mucormycosis is manifested by a wide variety of syndromes, devastating rhino-orbitalcerebral and pulmonary infections are the major presentation. The diagnosis of mucormycosis relies upon the identification of organisms in tissue, however culture often yields no growth. Mucormycosis are serious infections caused by filamentous fungi of the order Mucorales. Mucormycosis is a life-threatening infection caused by fungi of the order Mucorales. Recent reclassification has abolished the order Zygomycetes and placed the order Mucorales in the subphylum Mucormycotina. We report five cases of mucormycosis of patients hospitalized, In 2021. They were 4 males and 1 female, mean age 60 years. All patients were treated with amphotericin B and posiconazole.
毛霉病是一种与高死亡率相关的新发感染。这些真菌是非常常见的霉菌,接触可能相当频繁,但临床疾病罕见,影响严重免疫功能低下的患者或糖尿病患者。毛霉病表现为多种综合征,破坏性的鼻-眶-脑和肺部感染是主要表现。毛霉菌病的诊断依赖于组织中生物体的鉴定,然而培养通常不能产生生长。毛霉菌病是由毛霉菌目丝状真菌引起的严重感染。毛霉菌病是由毛霉菌目真菌引起的一种危及生命的感染。最近的重新分类已经取消了接合菌目,并将毛霉菌目置于毛霉菌亚门。我们报告了5例住院患者的毛霉病,在2021年。男性4例,女性1例,平均年龄60岁。所有患者均给予两性霉素B和泊康唑治疗。
{"title":"Mucormycosis: A Lethal Disease","authors":"P. Karwa, Jyoti K. Soundarmal, Pallavi S. Shinde, Swapna R. Jalde","doi":"10.52711/2231-5713.2022.00008","DOIUrl":"https://doi.org/10.52711/2231-5713.2022.00008","url":null,"abstract":"Mucormycosis is an emerging infection associated with high mortality. These fungi are very common molds to which exposure is probably quite frequent, still, clinical disease is rare and affects severely immunocompromised patients or patients with diabetes mellitus. Mucormycosis is manifested by a wide variety of syndromes, devastating rhino-orbitalcerebral and pulmonary infections are the major presentation. The diagnosis of mucormycosis relies upon the identification of organisms in tissue, however culture often yields no growth. Mucormycosis are serious infections caused by filamentous fungi of the order Mucorales. Mucormycosis is a life-threatening infection caused by fungi of the order Mucorales. Recent reclassification has abolished the order Zygomycetes and placed the order Mucorales in the subphylum Mucormycotina. We report five cases of mucormycosis of patients hospitalized, In 2021. They were 4 males and 1 female, mean age 60 years. All patients were treated with amphotericin B and posiconazole.","PeriodicalId":8527,"journal":{"name":"Asian Journal of Pharmacy and Technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73365788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Novel Route of Inhaled Insulin for Diabetes Treatment 吸入胰岛素治疗糖尿病的新途径
Pub Date : 2022-03-05 DOI: 10.52711/2231-5713.2022.00005
Komal. P. Kumbhar, S. S. Suryawanshi, S. Patil
Diabetes is a chronic condition characterised by insufficient insulin secretion and hyperglycemia as a result. Microvascular and macrovascular disease are two types of diabetic complications that are affected by good diabetes management. Many diabetics rely on subcutaneous insulin injections or continuous infusions to keep their blood sugar levels under control. Insulin delivery via new routes Since the 1920s, subcutaneous insulin has been used to treat diabetes; nevertheless, despite a variety of formulations, intensive insulin therapy including many daily injections has not acquired universal clinical approval. The search for a successful, well-tolerated nonenteral method for delivering insulin began in the 1920s, and has included ocular, buccal, rectal, vaginal, and other routes. Given that insulin injection therapy is burdensome for many patients, novel insulin administration routes are of interest in the diabetes sector. The use of inhalation to administer insulin to the lungs will be discussed in this review. Inhaled insulin's safety as well as efficacy in contrast to subcutaneous insulin in diverse diabetic populations are discussed. Until recently, many researchers considered that noninvasively given insulin had too low a bioavailability to be useful in clinical practise. Inhaled insulin, on the other hand, appears to be an effective, well-tolerated, and noninvasive alternative to subcutaneous regular insulin, according to a growing body of research. Importantly, inhaled insulin has a more physiological insulin profile than injectable insulin.
糖尿病是一种以胰岛素分泌不足和高血糖为特征的慢性疾病。微血管和大血管疾病是糖尿病并发症的两种类型,良好的糖尿病管理影响。许多糖尿病患者依靠皮下注射胰岛素或持续输液来控制血糖水平。自20世纪20年代以来,皮下胰岛素已被用于治疗糖尿病;然而,尽管有多种配方,强化胰岛素治疗包括许多日常注射尚未获得普遍的临床批准。寻找一种成功的、耐受性良好的非肠内给胰岛素的方法始于20世纪20年代,包括眼、口腔、直肠、阴道和其他途径。鉴于胰岛素注射治疗对许多患者来说是负担,新的胰岛素给药途径是糖尿病部门感兴趣的。本综述将讨论吸入给药胰岛素到肺部的方法。在不同的糖尿病人群中,吸入胰岛素的安全性以及与皮下胰岛素相比的有效性进行了讨论。直到最近,许多研究人员认为无创注射胰岛素的生物利用度太低,无法用于临床实践。另一方面,根据越来越多的研究,吸入胰岛素似乎是一种有效的、耐受性良好的、无创的替代皮下常规胰岛素的方法。重要的是,吸入胰岛素比注射胰岛素具有更多的生理胰岛素特征。
{"title":"Novel Route of Inhaled Insulin for Diabetes Treatment","authors":"Komal. P. Kumbhar, S. S. Suryawanshi, S. Patil","doi":"10.52711/2231-5713.2022.00005","DOIUrl":"https://doi.org/10.52711/2231-5713.2022.00005","url":null,"abstract":"Diabetes is a chronic condition characterised by insufficient insulin secretion and hyperglycemia as a result. Microvascular and macrovascular disease are two types of diabetic complications that are affected by good diabetes management. Many diabetics rely on subcutaneous insulin injections or continuous infusions to keep their blood sugar levels under control. Insulin delivery via new routes Since the 1920s, subcutaneous insulin has been used to treat diabetes; nevertheless, despite a variety of formulations, intensive insulin therapy including many daily injections has not acquired universal clinical approval. The search for a successful, well-tolerated nonenteral method for delivering insulin began in the 1920s, and has included ocular, buccal, rectal, vaginal, and other routes. Given that insulin injection therapy is burdensome for many patients, novel insulin administration routes are of interest in the diabetes sector. The use of inhalation to administer insulin to the lungs will be discussed in this review. Inhaled insulin's safety as well as efficacy in contrast to subcutaneous insulin in diverse diabetic populations are discussed. Until recently, many researchers considered that noninvasively given insulin had too low a bioavailability to be useful in clinical practise. Inhaled insulin, on the other hand, appears to be an effective, well-tolerated, and noninvasive alternative to subcutaneous regular insulin, according to a growing body of research. Importantly, inhaled insulin has a more physiological insulin profile than injectable insulin.","PeriodicalId":8527,"journal":{"name":"Asian Journal of Pharmacy and Technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87698892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
A Review: E-Pharmacy Vs Conventional Pharmacy 综述:电子药房与传统药房
Pub Date : 2022-03-05 DOI: 10.52711/2231-5713.2022.00014
Priti B. Savant, Manjusha S. Kareppa
Pharmaceutical industry in India is the third largest and fastest developing industry in India. An E-Pharmacy is a pharmacy that operates over the internet by selling drugs, medicines and sending them to the customers. Internet making all the things easy and convenient. Patients can now buy use of prescription of registered medical practitioner order the medicines via use of internet and receive them at their own doorsteps. Online pharmacy is one of the technology advancement in creating huge demand in the upcoming days. Though it is convenient to buy drugs online as it causes high risk of selfmedication and misuse of drugs especially coming under the schedule H and X, so to overcome these risks local pharmacy may be preferred. In this article we have discussed about difference between the E-pharmacy and conventional pharmacy. According to D and C act 1940 state that do not sell the drug like schedule X and schedule H drugs without prescription and without consent to the physician if pharmacist have doubt about the prescription. There are so many advantages of this facilities e-pharmacy on online pharmacy like as the cost effectiveness, free home deliver, instance serves, 24 X 7 availability. Similarly, when the technology is used for medical purposes, it gives rise to medico legal and techno legal issues with it. As when we deal with medicine there are number of drugs which are under schedule ‘H’ and schedule ‘X ‘. When this kind of medicines gets easily available then, obviously it will results into the wrong practice of the medication. This review article emphasize on e-pharmacy vs conventional pharmacy i.e. what is e-pharmacy, how does work is it safe today, online pharmacy is a boon or bane, what is conventional pharmacy Difference between online pharmacy and conventional pharmacy. etc.
印度的制药业是印度第三大、发展最快的产业。电子药房是一种通过互联网销售药品并将其发送给客户的药店。互联网使所有的事情都变得容易和方便。患者现在可以通过互联网购买、使用注册医生的处方、订购药物,并在自己家门口接收药物。在未来的日子里,在线药房是创造巨大需求的技术进步之一。网上购买药品虽然方便,但自用药物和滥用药物的风险较高,尤其是H、X类药品,因此为了克服这些风险,可能会首选当地药店。本文讨论了电子药房与传统药房的区别。根据1940年的D和C法案,如果药剂师对处方有疑问,那么在没有处方和未经医生同意的情况下,不得出售像X和H类药物这样的药物。与网上药店相比,电子药房有很多优势,如成本效益、免费送货上门、实例服务、24 × 7全天候可用。同样,当这项技术用于医疗目的时,它会产生医疗法律和技术法律问题。当我们处理药物时,有许多药物属于“H”和“X”表。当这种药物很容易获得时,显然会导致错误的用药方法。这篇综述文章强调了电子药房与传统药房的区别,即什么是电子药房,它是如何工作的,今天是安全的,网上药房是福还是祸,网上药房与传统药房的区别是什么。等。
{"title":"A Review: E-Pharmacy Vs Conventional Pharmacy","authors":"Priti B. Savant, Manjusha S. Kareppa","doi":"10.52711/2231-5713.2022.00014","DOIUrl":"https://doi.org/10.52711/2231-5713.2022.00014","url":null,"abstract":"Pharmaceutical industry in India is the third largest and fastest developing industry in India. An E-Pharmacy is a pharmacy that operates over the internet by selling drugs, medicines and sending them to the customers. Internet making all the things easy and convenient. Patients can now buy use of prescription of registered medical practitioner order the medicines via use of internet and receive them at their own doorsteps. Online pharmacy is one of the technology advancement in creating huge demand in the upcoming days. Though it is convenient to buy drugs online as it causes high risk of selfmedication and misuse of drugs especially coming under the schedule H and X, so to overcome these risks local pharmacy may be preferred. In this article we have discussed about difference between the E-pharmacy and conventional pharmacy. According to D and C act 1940 state that do not sell the drug like schedule X and schedule H drugs without prescription and without consent to the physician if pharmacist have doubt about the prescription. There are so many advantages of this facilities e-pharmacy on online pharmacy like as the cost effectiveness, free home deliver, instance serves, 24 X 7 availability. Similarly, when the technology is used for medical purposes, it gives rise to medico legal and techno legal issues with it. As when we deal with medicine there are number of drugs which are under schedule ‘H’ and schedule ‘X ‘. When this kind of medicines gets easily available then, obviously it will results into the wrong practice of the medication. This review article emphasize on e-pharmacy vs conventional pharmacy i.e. what is e-pharmacy, how does work is it safe today, online pharmacy is a boon or bane, what is conventional pharmacy Difference between online pharmacy and conventional pharmacy. etc.","PeriodicalId":8527,"journal":{"name":"Asian Journal of Pharmacy and Technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88348683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Coronavirus disease (COVID-19): A global threat 冠状病毒病(COVID-19):全球威胁
Pub Date : 2022-03-05 DOI: 10.52711/2231-5713.2022.00011
S. Debnath, Jaya Saha
Coronavirus (CoVs) is a type of enveloped RNA virus that is found in animals and humans. There are near about six different species of CoVs are available and all of them can cause different health issue to human. In human this virus can effect respiratory, hepatic, enteric and neurological system. The past Middle East respiratory syndrome coronavirus and severe acute respiratory syndrome coronavirus has been transmitted from animal to human. Presently there is a new strain of corona virus, named SARS-CoV-2, causing serious health crises to human. This virus is highly contagious and has resulted in a rapid pandemic of COVID-19. The number of infected people and death caused by COVID-19 is increasing day by day. This review will provide a detailed overview of COVID-19 and its serious effect to the human health.
冠状病毒(CoVs)是一种存在于动物和人类体内的包膜RNA病毒。目前大约有六种不同的冠状病毒,它们都可能对人类造成不同的健康问题。在人类中,这种病毒可影响呼吸系统、肝脏、肠道和神经系统。过去的中东呼吸综合征冠状病毒和严重急性呼吸综合征冠状病毒已经从动物传播给人类。目前出现了一种新的冠状病毒,命名为SARS-CoV-2,给人类造成了严重的健康危机。这种病毒具有高度传染性,已导致COVID-19迅速大流行。新冠肺炎感染人数和死亡人数日益增加。本文将详细介绍COVID-19及其对人类健康的严重影响。
{"title":"Coronavirus disease (COVID-19): A global threat","authors":"S. Debnath, Jaya Saha","doi":"10.52711/2231-5713.2022.00011","DOIUrl":"https://doi.org/10.52711/2231-5713.2022.00011","url":null,"abstract":"Coronavirus (CoVs) is a type of enveloped RNA virus that is found in animals and humans. There are near about six different species of CoVs are available and all of them can cause different health issue to human. In human this virus can effect respiratory, hepatic, enteric and neurological system. The past Middle East respiratory syndrome coronavirus and severe acute respiratory syndrome coronavirus has been transmitted from animal to human. Presently there is a new strain of corona virus, named SARS-CoV-2, causing serious health crises to human. This virus is highly contagious and has resulted in a rapid pandemic of COVID-19. The number of infected people and death caused by COVID-19 is increasing day by day. This review will provide a detailed overview of COVID-19 and its serious effect to the human health.","PeriodicalId":8527,"journal":{"name":"Asian Journal of Pharmacy and Technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77272907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
A Review on Emerging Oral Dosage Forms which helps to bypass the Hepatic First Pass Metabolism 新出现的有助于绕过肝脏第一关代谢的口服剂型综述
Pub Date : 2022-03-05 DOI: 10.52711/2231-5713.2022.00009
Vishal B. Mahanur, Rahul R. Rajge, M. Tawar
The initial pass metabolism or pre-circulatory system is a metabolic process in which the concentration of the drug is significantly reduced or shortened in the liver before it reaches the circulatory system. A fraction of the drug lost in the entire absorption process is often associated with the liver and skin wall. Oral delivery, the simplest form of drug management has its limitations, most of which are the low availability of drugs due to the first internal organ passing through metabolism. Drugs with low bioavailability need to be administered at a better dose as a small fraction of the controlled dose is injected into the bloodstream and reaches the target. Therefore, the worst dose of the drug is destroyed and the unauthorized drug ends up having unwanted side effects within the canal. Various forms of oral contraceptives are used. The current review focuses on the importance of passing the first hepatic pass, the biological findings, the reasons for the negative findings and the various methods used to skip the initial hepatic pass metabolism.
初过代谢或循环前系统是药物在到达循环系统之前在肝脏中的浓度显著降低或缩短的代谢过程。在整个吸收过程中损失的一部分药物通常与肝脏和皮肤壁有关。口服给药是最简单的药物管理方式,但也有其局限性,主要是由于药物首先要经过体内器官的代谢,所以药物的可得性较低。低生物利用度的药物需要以更好的剂量给药,因为控制剂量的一小部分被注射到血液中并达到目标。因此,最坏剂量的药物被破坏,未经授权的药物最终在管道内产生不必要的副作用。使用各种形式的口服避孕药。目前的综述重点是通过第一肝关的重要性,生物学结果,阴性结果的原因以及用于跳过初始肝关代谢的各种方法。
{"title":"A Review on Emerging Oral Dosage Forms which helps to bypass the Hepatic First Pass Metabolism","authors":"Vishal B. Mahanur, Rahul R. Rajge, M. Tawar","doi":"10.52711/2231-5713.2022.00009","DOIUrl":"https://doi.org/10.52711/2231-5713.2022.00009","url":null,"abstract":"The initial pass metabolism or pre-circulatory system is a metabolic process in which the concentration of the drug is significantly reduced or shortened in the liver before it reaches the circulatory system. A fraction of the drug lost in the entire absorption process is often associated with the liver and skin wall. Oral delivery, the simplest form of drug management has its limitations, most of which are the low availability of drugs due to the first internal organ passing through metabolism. Drugs with low bioavailability need to be administered at a better dose as a small fraction of the controlled dose is injected into the bloodstream and reaches the target. Therefore, the worst dose of the drug is destroyed and the unauthorized drug ends up having unwanted side effects within the canal. Various forms of oral contraceptives are used. The current review focuses on the importance of passing the first hepatic pass, the biological findings, the reasons for the negative findings and the various methods used to skip the initial hepatic pass metabolism.","PeriodicalId":8527,"journal":{"name":"Asian Journal of Pharmacy and Technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73834653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Solubilty Enhancement of Naproxen Sodium Using Different Carriers by Solid Dispersion 固体分散法提高萘普生钠的溶解度
Pub Date : 2022-03-05 DOI: 10.52711/2231-5713.2022.00001
Mogal Prasad S., Surawase Rajendra K.
In the existing study an attempt has been made to increase the in vitro dissolution rate of poorly water-soluble drug naproxen, by utilizing novel solid dispersion methods are one of the most auspicious methods to enhance the oral bioavailability of poorly water soluble drug. naproxen sodium formulations were planned out by using melting method or fusion method, and using carrier like PVP-K30 and PEG4000. the formulation were planned out with the above-mentioned carriers in three different drug-carrier (w/w) ratios of 1:1, 1:2 and 1:3. the prepared solid dispersion was subjected for percentage practical yield, drug content, and FTIR studies. absence of significant drug-carrier interaction was confirmed by FTIR data. in-vitro release profiles of all solid dispersions (SD1 to SD6) were analogously evaluated and also studied against pure naproxen sodium. solid dispersion of formulation (SD6) naproxen sodium and PVP-K30 combination planned out in (1:3) ratio showed excellent solubility and the dissolution rate was found to be 98.97% drug release at 24 min was chosen as the absolute best formulation in this study. solubility of naproxen sodium was increased as the concentration of carriers increased.
现有研究尝试利用新型固体分散方法提高难水溶性药物萘普生的体外溶出度,是提高难水溶性药物口服生物利用度的最佳方法之一。采用熔融法或熔融法,以PVP-K30和PEG4000为载体,规划萘普生钠的配方。将上述载体以1:1、1:2、1:3三种不同的药物载体(w/w)比设计处方。制备的固体分散体进行了实际产率百分比、药物含量和FTIR研究。FTIR数据证实没有明显的药物载体相互作用。对所有固体分散体(SD1至SD6)的体外释放谱进行了类似评价,并对纯萘普生钠进行了研究。以(1:3)比例设计的萘普生钠与PVP-K30组合的固体分散体(SD6)具有良好的溶解度,溶出率为98.97%,24 min释药为本研究的绝对最佳配方。萘普生钠的溶解度随着载体浓度的增加而增加。
{"title":"Solubilty Enhancement of Naproxen Sodium Using Different Carriers by Solid Dispersion","authors":"Mogal Prasad S., Surawase Rajendra K.","doi":"10.52711/2231-5713.2022.00001","DOIUrl":"https://doi.org/10.52711/2231-5713.2022.00001","url":null,"abstract":"In the existing study an attempt has been made to increase the in vitro dissolution rate of poorly water-soluble drug naproxen, by utilizing novel solid dispersion methods are one of the most auspicious methods to enhance the oral bioavailability of poorly water soluble drug. naproxen sodium formulations were planned out by using melting method or fusion method, and using carrier like PVP-K30 and PEG4000. the formulation were planned out with the above-mentioned carriers in three different drug-carrier (w/w) ratios of 1:1, 1:2 and 1:3. the prepared solid dispersion was subjected for percentage practical yield, drug content, and FTIR studies. absence of significant drug-carrier interaction was confirmed by FTIR data. in-vitro release profiles of all solid dispersions (SD1 to SD6) were analogously evaluated and also studied against pure naproxen sodium. solid dispersion of formulation (SD6) naproxen sodium and PVP-K30 combination planned out in (1:3) ratio showed excellent solubility and the dissolution rate was found to be 98.97% drug release at 24 min was chosen as the absolute best formulation in this study. solubility of naproxen sodium was increased as the concentration of carriers increased.","PeriodicalId":8527,"journal":{"name":"Asian Journal of Pharmacy and Technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91021332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overview of Pharmacognostical and Pharmacological properties of Moringa oleifera 辣木生药学及药理特性综述
Pub Date : 2022-03-05 DOI: 10.52711/2231-5713.2022.00013
Sneha Mali, Sonam Bendre, S. Patil
Moringa oleifera (family Moringaceae) is one of the widely cultivated plant in India. Moringa oleifera is widely known as drumstick tree. This plant contains various nutritional properties such as it is a rich source of Vitamins (A and C) as well as it contains lots of minerals (Ca, P, K, Fe, Cu, S, Mg) etc. Every single part of Moringa oleifera plant comprises a valuable medicinal feature. From Past two decades, several reports have been published which describes nutritional and medicinal properties of this plant. Moringa oleifera are well-known for their valuable pharmacological action such as anti-fertility, anti-microbial, anti-asthmatic, antioxidant, anti-diabetic, anti-inflammatory, anticancer, anti-hyperglycemic activity and many more. Most of biological of activities of Moringa oleifera is caused by their presence of huge amount of flavonoids, glycosides, as well as glucosinolates. The purpose of this review is to provide all the essential Pharmacognostical, Phytochemical as well as Pharmacological information of Moringa oleifera.
辣木(辣木科)是印度广泛种植的植物之一。辣木被广泛称为鸡腿树。这种植物含有多种营养成分,如它是维生素(a和C)的丰富来源,以及它含有大量的矿物质(Ca, P, K, Fe, Cu, S, Mg)等。辣木的每一个部分都含有有价值的药用特性。在过去的二十年里,已经发表了一些报告,描述了这种植物的营养和药用特性。辣木素以其抗生育、抗微生物、抗哮喘、抗氧化、抗糖尿病、抗炎、抗癌、抗高血糖等药理作用而闻名。辣木的大部分生物学活性是由于其含有大量的黄酮类化合物、糖苷类化合物和硫代葡萄糖苷类化合物。本文综述了辣木的生药学、植物化学和药理研究方面的最新进展。
{"title":"Overview of Pharmacognostical and Pharmacological properties of Moringa oleifera","authors":"Sneha Mali, Sonam Bendre, S. Patil","doi":"10.52711/2231-5713.2022.00013","DOIUrl":"https://doi.org/10.52711/2231-5713.2022.00013","url":null,"abstract":"Moringa oleifera (family Moringaceae) is one of the widely cultivated plant in India. Moringa oleifera is widely known as drumstick tree. This plant contains various nutritional properties such as it is a rich source of Vitamins (A and C) as well as it contains lots of minerals (Ca, P, K, Fe, Cu, S, Mg) etc. Every single part of Moringa oleifera plant comprises a valuable medicinal feature. From Past two decades, several reports have been published which describes nutritional and medicinal properties of this plant. Moringa oleifera are well-known for their valuable pharmacological action such as anti-fertility, anti-microbial, anti-asthmatic, antioxidant, anti-diabetic, anti-inflammatory, anticancer, anti-hyperglycemic activity and many more. Most of biological of activities of Moringa oleifera is caused by their presence of huge amount of flavonoids, glycosides, as well as glucosinolates. The purpose of this review is to provide all the essential Pharmacognostical, Phytochemical as well as Pharmacological information of Moringa oleifera.","PeriodicalId":8527,"journal":{"name":"Asian Journal of Pharmacy and Technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83465312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
期刊
Asian Journal of Pharmacy and Technology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1